-
Sector Analysis
Diabetic Foot Ulcers Treatment Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hospitals and Specialty Clinics, Others) and Segment Forecast, 2022-2027
The diabetic foot ulcers market size was valued at US$ 4.74 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during 2022-2027. The key to the growth has been the rising prevalence of diabetes and resulting increase in incidence of diabetic foot ulcers. Additionally, rise in geriatric population, and increasing adoption of novel biologics and wound care devices for treatment, favoring diabetic foot ulcers market growth.
-
Sector Analysis
EpiCast Report: Dyslipidemia – Epidemiology Forecast to 2025
Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascular disease (CVD), and the burden of morbidity, mortality, and medical costs arising from dyslipidemia is substantial The clinical diagnostic criteria for dyslipidemia and serum lipid abnormalities vary across countries and depend on the disease treatment and management guidelines that are followed in each country. Guidelines for the detection, evaluation, treatment, and management of dyslipidemia, as well...
-
Product Insights
Tay-Sachs Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Tay-Sachs Disease Global Clinical Trials Review, H2, 2016" provides an overview of Tay-Sachs Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Tay-Sachs Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016" provides an overview of Becker Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Becker Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2016" provides an overview of Glycogen Storage Disorders (GSD) clinical trials scenario. This report provides top line data relating to the clinical trials on Glycogen Storage Disorders (GSD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2016" provides an overview of Alpha- Antitrypsin Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Alpha- Antitrypsin Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Fabry Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, H2, 2016" provides an overview of Fabry Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Fabry Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Hyperparathyroidism – Epidemiology Forecast to 2025
HPT is a disorder of the parathyroid gland that is caused due to presence of excessive parathyroid hormone (PTH) in the bloodstream. An increase in the activity of parathyroid glands, due to intrinsic abnormal changes, causes alteration of the excretion of PTH, and is known as PHPT. However, an extrinsic abnormal change affecting calcium homoeostasis, which stimulates production of PTH, is known as SHPT. In THPT, a state of autonomous secretion of PTH usually occurs as a result of longstanding...
-
Product Insights
Pompe Disease Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2016" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.